Key Takeaways
- San Francisco Fed President Mary Daly indicated the Federal Reserve is in a "good place" after recent policy adjustments but warned against holding interest rates too long, emphasizing that slowing wage growth signals a negative demand shock in the labor market.
- Novo Nordisk's Wegovy® (semaglutide 2.4 mg) demonstrated significant liver health benefits in adult patients with metabolic dysfunction-associated steatohepatitis (MASH) and liver scarring, with effects observed beyond mere weight loss.
- The U.S. government removed Arrow China Electronics Trading and its affiliates from the Entity List, reversing earlier trade restrictions and allowing the company to resume normal transactions.
- Coinbase (COIN) launched a new platform designed for digital token offerings, enabling individual investors to acquire new tokens before their general exchange listing.
- Israeli government spokespersons reiterated Prime Minister Netanyahu's discussions with U.S. officials, including Jared Kushner, regarding the disarming of Hamas and the demilitarization of Gaza.
Federal Reserve Bank of San Francisco President Mary Daly provided insights into the current economic landscape and monetary policy, highlighting the Fed's careful approach to interest rates. Daly stated that the Federal Open Market Committee (FOMC) has historically been more divided than it is now, but emphasized that the Fed is in a "good place" following a slight adjustment in policy. She cautioned against the mistake of holding onto rates for too long, suggesting that policy remains somewhat tight even after recent reductions.
Daly noted that inflation data does not show rising trends in services, housing, or inflation expectations, and goods inflation has been "pretty contained so far". She also observed that productivity and GDP are rising while the labor market is slowing, with slowing wage growth indicating a "negative demand shock". Asset valuations, according to Daly, reflect higher productivity expectations, regardless of whether AI proves to be transformative.
In pharmaceutical news, Novo Nordisk (NVO) announced significant findings regarding its blockbuster drug, Wegovy® (semaglutide 2.4 mg). A new post hoc analysis revealed that Wegovy was associated with liver health-related benefits in adult patients with MASH and liver scarring, and these benefits were not solely dependent on weight loss. This expands the potential therapeutic scope of semaglutide beyond its established indications for weight management and diabetes.
In a notable development for U.S.-China trade relations, Arrow China Electronics Trading and its affiliates were removed from the U.S. Commerce Department's Entity List. This reversal lifts previous trade restrictions, allowing Arrow Electronics (ARW) to resume normal transactions with these entities. The initial listing had been based on allegations that components distributed by these firms were found in drones used by Iran-backed groups.
The cryptocurrency market saw Coinbase (COIN) launch a new platform for digital token offerings. This initiative will allow individual investors to purchase digital tokens before they are officially listed on the exchange, with the Wall Street Journal reporting that blockchain startup Monad will be the first project to sell tokens through this service. The platform is expected to host approximately one token sale per month.
Meanwhile, in geopolitical discussions, an Israeli government spokesperson confirmed that Prime Minister Benjamin Netanyahu and Jared Kushner discussed critical post-conflict plans for Gaza. These discussions focused on disarming Hamas, demilitarizing Gaza, and ensuring Hamas has no future role in the territory. The spokesperson also indicated that any decisions regarding trapped Hamas fighters would be made in collaboration with the Trump administration.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.